Novartis India Limited primarily trades in drugs and pharmaceuticals. The company offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences. It also provides generics medicines for anti-TB, anti-infective, and gynecology; and tyrosine kinase inhibitor for cancer under Glive brand name, as well as eye care products. The company offers central nervous system products under the Tegrital and Exelon brand name; pain and Inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic Sandimmun, and Neoral brand names. In addition, it provides consignment, clinical research support, and field force support services. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. The ISIN of this stock is INE234A01025.